Genmark Diagnostics Inc (GNMK) Return on Investment ROI from the fourth quarter of 2020 to fourth quarter of 2019 and for the year 2020, average high and low, overall ranking from Dec 31 2020 to Dec 31 2019 - CSIMarket
CSIMarket
 


Genmark Diagnostics Inc   (NASDAQ: GNMK)


Genmark Diagnostics Inc's ROI from its fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Genmark Diagnostics Inc's ROI in the fourth quarter of 2020?
Genmark Diagnostics Inc recorded a cumulative net loss of $-19 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on investment (ROI) of -13.05%.

Within the Healthcare sector 312 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2020 from 3504 to 3678.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Investment Change TTM 104.18 % 85.36 % 36.49 % 2.23 % -3.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 167 165 161 79 87
Return On Investment (TTM) -13.05 % -20.49 % -35.02 % -58.95 % -67.66 %
GNMK's Overall Ranking # 3678 # 3504 # 3788 # 4091 # 4668
Seq. Investment Change TTM 16.16 % 28.01 % 34 % 2.48 % 5.45 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -19 -25 -34 -42 -47




Return On Investment GNMK's Ranking
Within: No.
Industry # 92
Sector # 313
Overall # 3678

Return On Investment Statistics
High Average Low
-12.35 %
-56.43 %
-98.4 %
(Dec 31 2020)   (Mar 31 2017)







Financial Statements
Genmark Diagnostics Inc's IV. Quarter Investments $ 167 Millions GNMK's Balance sheet
Genmark Diagnostics Inc's IV. Quarter Income $ -4 Millions Quarterly GNMK's Income Statement
GNMK's Income by Division See GNMK's Income by Division


GNMK Annual Return On Investment (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2017
(Dec 31 2016)
2015
(Dec 31 2014)
2014
Total Investments in Millions 167 87 73 54 80
Y / Y Investment Growth 91.21 % 19.9 % 34.86 % -32.35 % -28.55 %
Net Income in Millions -19 -47 -51 -51 -38
Y / Y Net Income Growth - - - - -
Annual Return On Investment -11.19 % -54.33 % -69.47 % -93.87 % -48.02 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GNMK's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GNMK's Competitors
Subscribers only: Roi for Genmark Diagnostics Inc's Suppliers
Subscribers only: Return On Investment for GNMK's Customers

Other Ratios
GNMK's Roa GNMK's Inventory Turnover Ratio GNMK's Growth Rates GNMK's Dividend Statistics
GNMK's Profitability Ratios GNMK's Asset Turnover Ratio GNMK's Dividend Growth
GNMK's Roe GNMK's Valuation Ratios GNMK's Financial Strength Ratios GNMK's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2020, within Healthcare Sector ROI


Date modified: 2026-09-08T15:10:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.